COA Response to Senate RFI on 340B Drug Pricing Program
On behalf of the Board of Directors of the Community Oncology Alliance (“COA”), we are submitting this response to the Senate RFI seeking input on the 340B Drug Pricing Program (“340B”).
COA 2022 PBM Dirty Tricks Exposé Report
There is growing awareness of the problems and pitfalls with Pharmacy Benefit Managers (PBMs) in the United States health care system. Contracted by plan sponsors (including government programs, self-insured employers, and insurance companies) to negotiate on their behalf with pharmaceutical companies, these “middlemen” corporations have quietly become an unavoidable part of our nation’s health care system.
Billy Harper
With over 32 years of experience in the computer industry, Billy Harper brings a breadth of expertise to COA as the Director of IT and Web Services. The digital nature of today’s world means he touches every aspect of COA operations, including member data management, website architecture and implementation, technology acquisition, and more. He
Bo Gamble
In his current position with COA, Bo Gamble has been responsible for the development of the principles and metrics associated with the Oncology Medical Home (OMH) program. Working with COA members and payers, the OMH program was developed in 2012 and participating practices began using this practice model immediately. Robert “Bo” Gamble joined the
Bo Gamble
In his current position with COA, Bo Gamble has been responsible for the development of the principles and metrics associated with the Oncology Medical Home (OMH) program. Working with COA members and payers, the OMH program was developed in 2012 and participating practices began using this practice model immediately. Robert “Bo” Gamble joined the
Patient Practice Connector Thank You
Thank you for submitting a request to the COA Patient-Practice Connector. We will get in touch with you shortly and strive to respond within 24 business hours. If you have any questions or concerns, please email us at info@coacancer.org.
Coding concerns: Providers decry proposed cuts to infusion services in 2023 fee schedule
Providers are slamming the Biden administration’s proposal to cut reimbursements for procedure codes that cover oncology, hematology and other infusion services.
OCM Successor Puts Focus on Equity in Cancer Care—With Fewer Dollars for Services
Days before it expired, CMS announced a replacement for the Oncology Care Model (OCM) that officials say will put more focus on health equity—but with less money to offer services that physicians say have improved patients’ lives.
Here are 4 key health policy items in the Inflation Reduction Act
The House passed on late Friday a sweeping healthcare, climate and taxes package that includes major reforms on drug prices and extends boosted Affordable Care Act subsidies through 2025.
How coronavirus vaccines saved oncologist-patient relationship
The community cancer care landscape in the United States has been changing rapidly over the past decade, and not for the better.
